A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Table 3. Notification rates of diseases by state and territory, 1 October to 31 December 2004. (Rate per 100,000 population)
| State or territory | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Disease* |
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | Australia |
Bloodborne diseases |
|||||||||
| Hepatitis B (incident) | 3.7 |
0.7 |
4.0 |
1.4 |
0.5 |
4.1 |
2.1 |
0.6 |
1.3 |
| Hepatitis B (unspecified) | 9.9 |
49.1 |
NN |
23.3 |
19.0 |
10.0 |
29.8 |
22.2 |
32.3 |
| Hepatitis C (incident) | 2.5 |
0.8 |
NN |
NN |
2.9 |
8.3 |
0.2 |
6.5 |
1.4 |
| Hepatitis C (unspecified) | 50.6 |
92.2 |
160.1 |
72.5 |
32.3 |
49.8 |
59.0 |
56.1 |
71.0 |
| Hepatitis D | 0.0 |
0.2 |
0.0 |
0.2 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
Gastrointestinal diseases |
|||||||||
| Botulism | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Campylobacteriosis† | 153.1 |
NN |
94.0 |
117.5 |
145.7 |
169.3 |
153.2 |
103.3 |
89.3 |
| Cryptosporidiosis | 0.0 |
4.7 |
44.0 |
19.8 |
7.6 |
2.5 |
8.0 |
3.8 |
8.8 |
| Haemolytic uraemic syndrome | 0.0 |
0.2 |
0.0 |
0.1 |
0.5 |
0.0 |
0.0 |
0.0 |
0.1 |
| Hepatitis A | 0.0 |
1.7 |
6.0 |
1.0 |
0.5 |
0.0 |
1.2 |
0.4 |
1.2 |
| Hepatitis E | 0.0 |
0.1 |
0.0 |
0.3 |
0.0 |
0.0 |
0.2 |
0.2 |
0.2 |
| Listeriosis | 0.0 |
0.4 |
0.0 |
0.1 |
0.0 |
0.0 |
0.4 |
0.4 |
0.3 |
| Salmonellosis (NEC) | 17.3 |
32.0 |
178.1 |
72.8 |
40.7 |
31.5 |
21.5 |
30.9 |
39.0 |
| Shigellosis | 1.2 |
1.7 |
64.0 |
1.8 |
1.6 |
0.8 |
1.5 |
5.9 |
2.6 |
| SLTEC,VTEC‡ | 0.0 |
0.1 |
0.0 |
0.1 |
3.1 |
0.0 |
0.0 |
0.0 |
0.3 |
| Typhoid | 0.0 |
0.8 |
0.0 |
0.1 |
0.0 |
0.0 |
0.1 |
0.0 |
0.3 |
Quarantinable diseases |
|||||||||
| Cholera | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Plague | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rabies | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Smallpox | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Tularemia | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Viral haemorrhagic fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Yellow Fever | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmissible infections |
|||||||||
| Chlamydial infection | 196.3 |
141.1 |
804.4 |
233.3 |
154.9 |
173.4 |
154.5 |
224.2 |
179.7 |
| Donovanosis | 0.0 |
0.0 |
4.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.2 |
0.1 |
| Gonococcal infection | 17.3 |
17.6 |
732.4 |
30.9 |
26.1 |
7.5 |
21.9 |
77.3 |
34.6 |
| Syphilis (unspecified) | 2.5 |
0.0 |
0.0 |
0.0 |
0.3 |
0.0 |
0.0 |
0.0 |
0.1 |
| Syphilis < two years duration | 0.0 |
2.5 |
44.0 |
1.5 |
0.5 |
0.8 |
2.1 |
2.4 |
2.4 |
| Syphilis - > two years duration | 0.0 |
13.1 |
80.0 |
2.5 |
0.0 |
5.8 |
6.6 |
7.3 |
8.2 |
| Syphilis - congenital | 0.0 |
0.0 |
4.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Vaccine preventable diseases |
|||||||||
| Diphtheria | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Haemophilus influenzae type b | 0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Influenza (laboratory confirmed) | 0.0 |
22.9 |
30.0 |
16.5 |
8.3 |
0.0 |
5.1 |
20.2 |
15.0 |
| Measles | 0.0 |
0.2 |
2.0 |
0.0 |
0.3 |
0.0 |
0.2 |
1.2 |
0.3 |
| Mumps | 0.0 |
1.2 |
0.0 |
0.7 |
0.8 |
0.0 |
0.0 |
0.6 |
0.7 |
| Pertussis | 53.1 |
59.8 |
30.0 |
45.9 |
103.0 |
5.0 |
27.4 |
182.4 |
62.8 |
| Pneumococcal disease (invasive) | 8.6 |
9.4 |
42.0 |
9.8 |
12.8 |
9.1 |
5.7 |
9.1 |
9.1 |
| Poliomyletis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Rubella | 0.0 |
0.1 |
0.0 |
0.4 |
0.3 |
0.0 |
0.1 |
0.6 |
0.2 |
| Rubella - congenital | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Tetanus | 0.0 |
0.0 |
0.0 |
0.0 |
0.3 |
0.0 |
0.0 |
0.0 |
0.0 |
Vectorborne diseases |
|||||||||
| Barmah Forest virus infection | 1.2 |
5.1 |
8.0 |
14.3 |
0.5 |
0.0 |
0.5 |
4.0 |
5.1 |
| Dengue | 0.0 |
0.4 |
0.0 |
0.6 |
0.0 |
0.0 |
0.1 |
0.4 |
0.3 |
| Flavivirus NEC | 0.0 |
0.1 |
0.0 |
1.9 |
0.0 |
0.0 |
0.0 |
0.0 |
0.4 |
| Japanese encephalitis | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Kunjin virus | 0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
| Malaria | 6.2 |
1.5 |
48.0 |
6.4 |
1.8 |
5.0 |
1.3 |
1.8 |
3.1 |
| Murray Valley encephalitis | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ross River virus infection | 0.0 |
3.9 |
36.0 |
7.7 |
5.0 |
0.0 |
0.5 |
8.9 |
4.5 |
Zoonoses |
|||||||||
| Anthrax | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Australian bat lyssavirus | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Brucellosis | 0.0 |
0.1 |
0.0 |
1.4 |
0.0 |
0.0 |
0.1 |
0.0 |
0.3 |
| Leptospirosis | 0.0 |
0.6 |
2.0 |
0.6 |
0.5 |
0.0 |
0.3 |
0.4 |
0.5 |
| Lyssavirus (NEC) | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Ornithosis | 0.0 |
1.1 |
0.0 |
0.1 |
0.0 |
0.0 |
2.3 |
0.2 |
1.0 |
| Q fever | 1.2 |
3.1 |
0.0 |
1.9 |
6.3 |
0.0 |
0.2 |
0.6 |
2.0 |
Other bacterial infections |
|||||||||
| Legionellosis | 0.0 |
1.0 |
0.0 |
1.6 |
3.1 |
0.0 |
1.6 |
2.8 |
1.6 |
| Leprosy | 0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| Meningococcal infection | 1.2 |
1.9 |
6.0 |
3.7 |
0.0 |
1.7 |
0.9 |
2.2 |
1.9 |
| Tuberculosis | 3.7 |
7.5 |
10.0 |
4.4 |
2.6 |
0.8 |
8.8 |
5.0 |
6.4 |
* Rates are subject to retrospective revision.
† Not reported for New South Wales because it is only notifiable as 'foodborne disease' or 'gastroenteritis in an institution'.
‡ Infections with Shiga-like toxin (verotoxin) producing Escherichia coli (SLTEC/VTEC).
NN Not notifiable.
NEC Not Elsewhere Classified.
This article was published in Communicable Diseases Intelligence Vol 29 No 1 March 2005.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 29 No 1, March 2005
Communicable Diseases Intelligence